• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Journal article

Is there still a need for specific central nervous system directed prophylaxis for diffuse large B-cell lymphoma in the rituximab era?

CY Cheah, JF Seymour

Leukemia and Lymphoma | TAYLOR & FRANCIS LTD | Published : 2014

DOI: 10.3109/10428194.2013.830306

University of Melbourne Researchers

John Seymour's Profile Picture
John Seymour Author

Keywords

Science & Technology
Immunotherapy
Involvement
Lymphoma
Life Sciences & Biomedicine
Risk-Factors
Elderly-Patients
Lymphatic Research
3201 Cardiovascular Medicine and Haematology
Non-Hodgkins-Lymphoma
Trial
Chop Chemotherapy
Hematology
Methotrexate
Rare Diseases
32 Biomedical and Clinical Sciences
Orphan Drug
Cancer
3211 Oncology and Carcinogenesis
Oncology
Neurosciences
Cns Prophylaxis

Acknowledgement of Country

We acknowledge Aboriginal and Torres Strait Islander people as the Traditional Owners of the unceded lands on which we work, learn and live. We pay respect to Elders past, present and future, and acknowledge the importance of Indigenous knowledge in the Academy.

Read about our Indigenous priorities

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Campus locations  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia

facebookIconlinkedinIconinstagramIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy

CRICOS number: 00116K     ABN: 84 002 705 224